Background: Contemporary transcatheter aortic valve implantation (TAVI) devices and approach present opportunities to review historical practices initially informed by early treatment development and cardiac surgery. The avoidance of urinary catheterization in the older TAVI population is a strategy to minimize in-hospital complications. The purpose of the study was to explore elimination-related complications following the phased implementation of a default strategy of avoiding urinary catheterization in patients undergoing transfemoral (TF) TAVI. Methods: We conducted an observational study using a retrospective chart review of patients treated between 2011 and 2013 to identify patient characteristics, peri-procedure details, in-hospital outcomes and elimination-related complications in patients who did or did not receive a peri-procedure indwelling catheter. Descriptive analyses were used to report differences between the groups; we conducted a regression analysis to explore the relationship between the practice of urinary catheterization and total procedure time. Results: Of the 408 patients who underwent TF TAVR, 188 (46.1%) received a peri-procedure indwelling urinary catheter and 220 (53.9%) did not. There was no difference in in-hospital mortality (2.2%), disabling stroke (0.5%), or other major cardiac adverse events. The avoidance of a urinary catheter resulted in significantly lower rates of urinary tract infection requiring a new antibiotic regimen (1.4% versus 6.1%, p = 0.014), haematuria documented by medicine or nursing (3.7% versus 17.6%, p = 0.001), and the need for continuous bladder irrigation (2.7% versus 0%, p = 0.027).
Introduction

Transcatheter aortic valve implantation in transition
Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure that avoids the clinical implications associated with sternotomy, cardio-pulmonary bypass, longer surgical procedure time and critical care admission. 1 TAVI programs require procedural and recovery practices tailored to the specific needs of the procedure and the health vulnerabilities of patients who are most often older than 80 years. 2 There is emerging evidence that procedural success can be jeopardized by concomitant and potentially avoidable complications related to hospital admission of the frail elderly. 3 TAVI is in transition. 4 The adoption of minimalist TAVI and other practice changes to reduce length of stay and optimize outcomes are gaining interest. 5, 6 There is increasing evidence that the use of local anaesthesia or monitored anaesthesia care, the avoidance of invasive monitoring equipment, the transition from the operating room to the cardiac catheterization laboratory, and early discharge are safe and feasible interventions to improve outcomes and healthcare resource utilization. 7, 8 
Urinary catheterization: Not a benign intervention
Historically, the use of urinary catheterization for TAVI patients was an established practice in many centres. 9 The standard of care developed as a carry-over practice from cardiac surgery in view of the long procedure times during the early TAVI years and the management of potential complications. There is increasing awareness that urinary catheterization is associated with adverse outcomes, and merits careful consideration. In a 2008 review of nearly 36,000 United States Medicare patients undergoing a major operation (cardiac, vascular, abdominal colorectal surgery, or hip or knee total join arthroplasty), 86% of patients had perioperative indwelling urinary catheters. A post-operative catheterization longer than 2 days was associated with an increased likelihood of in-hospital urinary tract infection (UTI) and 30-day mortality, as well as a decreased likelihood of discharge home. 10 The development of catheter-associated UTI accounts for nearly 40% of all hospital-acquired infections, 11 and is associated with increased length of hospital stay and health care costs. 12 Urinary catheterization is an independent predictor of delirium, which is further associated with functional decline at discharge, and increased 12-month mortality in hospitalized older patients. 13 Previous studies have reported an estimated mortality as high as 10% in patients with a hospitalacquired catheter-associated UTI and concurrent bacteraemia. 14 The Institute for Healthcare Improvement has championed the adoption of strategies to reduce the use of urinary catheters and mitigate the risks of catheter-associated UTIs. 15 Primary recommendations centre on avoiding the placement of urinary catheter for inappropriate indications. 16 Changes in practice involving the avoidance or early removal of urinary catheters results in raised awareness of risks associated with inappropriate catheterization, reduced catheterization time and hospital length of stay, and improved patient outcomes. 17 
Context of care, local problem and rationale
The Centre for Heart Valve Innovation at St. Paul's Hospital, Vancouver Canada consists of a multidisciplinary heart team with extensive experience in TAVI procedure, technology, imaging, and program development. The implementation of the Vancouver TAVI Clinical Pathway capitalized on the availability of improved devices and pre-procedure multimodality imaging, enabled individual risk stratification and the adoption of minimalist peri-procedure practices, and promoted the standardization of post-procedure care. 3 The anecdotal awareness of adverse outcomes associated with the routine use of urinary catheterization was the rationale for the introduction of a nurse-initiated practice change to avoid urinary catheterization of transfemoral (TF) TAVI patients as a component of a minimalist approach and strategy to reduce length of stay.
The study was designed within a larger shift in practice focused on the central concept that less may be better for the older TAVI patient population. The avoidance of urinary catheterization was introduced in 2012 as a component of the transition to minimalist strategies ( Figure 1) .
The purpose of the study was to determine if the avoidance of a urinary catheter was associated with a reduction of urinary catheter-related complications including UTI, haematuria, and the need for continuous bladder irrigation. A secondary goal was to explore whether the change in practice was associated with shorter procedure times. The intent was to highlight opportunities for cardiovascular nurses to contribute to improved outcomes after TAVI by incorporating best practices of the care of the older person, and lead the critical examination of historical practices in this rapidly evolving clinical context. This manuscript examines the findings of a retrospective review of a single but pivotal component of the transformation of TAVI processes of care.
Methods
We employed an observational study design to examine the incidence of elimination-related complications before and after the change in practice. This design was predicated by the constraints of multiple evolving practices over the study period, and the inability to randomize or rigorously match patients given the dynamic clinical context. To this end, we conducted a retrospective chart review of all TF TAVIs completed between January 2011 and December 2013 at St. Paul's Hospital, Vancouver Canada, to capture procedures conducted before, during, and after the change in practice (Figure 2 ). We adopted a recommended systematic approach to the conduct of the chart review. 18, 19 The research questions were informed by the findings of the literature and focused on unique health vulnerabilities of older adults and the adverse outcomes associated with urinary catheterization, and clinicians' input. We operationalized the variables and developed a data abstraction instrument to ensure standardized data collection by researchers (SL and LS) who were trained to optimize interrater reliability. Criteria for power calculation was met based on the identification of 35 variables of interest, and the recommendation that the minimal sample size should be no less than 10 cases per variable. 20 The patient records were located with the assistance of the TAVI program. A pilot test confirmed the feasibility of the study.
In the absence of a definite time cut-off delineating the transition to the avoidance of urinary catheterization, we separated patients in two cohorts based on whether they received a urinary catheter at the time of their index procedure. We excluded aborted procedures (n = 5), peri-procedure deaths (n = 2), and patients on chronic dialysis (n = 13). There were no conversions to surgical aortic valve replacement during the study period.
Patient characteristics and procedural details were drawn from the chart review conducted by the investigators. In-hospital clinical outcomes were adjudicated using standardized definitions of the Valve Academic Research Consortium. 21 The identification of urinary catheterrelated complications was conducted using a systematic review of clinical documents. An incidence of haematuria and the use of continuous bladder irrigation were recorded when noted in nursing or physician documentation. The presence of UTI was defined as a new prescription for oral or intravenous antibiotics in the presence of a positive urine culture or medical diagnosis. The investigation was in keeping with the principles outlined in the Declaration of Helsinki. 22 The analytical plan consisted of an exploratory and primarily descriptive evaluation. We report on the patient characteristics, procedural details, and in-hospital outcomes of the total cohort, and compare the findings of the patients who received or did not receive a peri-procedure urinary catheter. The roll-out of the practice change did not include provisions or criteria for patients who should continue to receive a urinary catheter. Thus, we made an assumption that the two cohorts were treated according to the protocols in place at the time, and set a significance value of p < .05 to investigate differences between the groups. To meet the secondary aim of the study, we conducted a regression analysis to explore the relationship between total procedure time and various factors.
Informed by the literature review and clinicians' input, we hypothesized that Society of Thoracic Surgeons (STS) predicted risk of mortality score and baseline left ventricular ejection fraction were surrogate indicators of patients' clinical presentation, and that anaesthesia type (general anaesthesia versus local anaesthesia or monitored anaesthesia care) and the use of a peri-procedure urinary catheter represented major changes in practice during the evaluation period. We recognize that the selection of this conceptually-driven set of variables may fail to account for the multiplicity of indicators and evolving practice changes that could contribute to the investigated outcome. Nevertheless, this exploratory and retrospective study warranted a pragmatic approach informed by the literature to investigate the impact of the practice change. Assumptions of linearity, homogeneity of variance, and multicollinearity were checked, indicating the aptness of the underlying regression model.
Results
The patient cohort included 408 patients; 188 (46.1%) received a peri-procedure urinary catheter (January 2011 to August 2012) and 220 (53.9%) did not (January 2012 to December 2013).
Patient characteristics are outlined in Table 1 . Patients did not differ in age (82 ± 7.4 years), sex (40.4% female), markers of severity of aortic stenosis or most co-morbidities. There were significant differences in the reported STS risk score, and pre-existing severe pulmonary disease and atrial fibrillation. Differences in peri-procedural details reflect the multiple changes in practice that occurred during the time of the evaluation ( Table 2) . Procedures were increasingly performed in a cardiac catheterization laboratory (8.5% to 16.4%, p = 0.018), with a shift to a standard strategy of local anaesthesia or monitored anaesthesia care (2.2% to 28.9%, p = 0.001). Procedure time from patient entry to exit decreased from 151 ± 33 to 142 ± 36 min (p = 0.001). There were no differences in in-hospital outcomes (Table 3) . Overall in-hospital mortality was 2.2%, while 0.5% experienced a disabling stroke, and 1.7% sustained an acute kidney injury. Length of stay decreased significantly from a median of 4 (interquartile range (IQR) 3,6) to 3 (IQR 2,4) days (p = 0.001).
The chart review revealed significant differences in urinary elimination events and complications (Table 4) . The median insertion time of the peri-procedure urinary catheter was 24 hours (IQR 18,45) in keeping with the standard physician orders in place at the time prescribing the removal the morning following the procedure. After the initial removal of the device, 8.9% of patients required a repeat post-procedure intermittent or indwelling urinary catheter, and 18.8% of patients who underwent the index procedure without a urinary catheter required subsequent intermittent (16.1%) or indwelling (2.7%) catheterization. The avoidance of a urinary catheter was associated with significantly lower rates of UTI (1.4% versus 6.1%, p = 0.014), haematuria (3.7% versus 17.6%, p = 0.001), and the need for continuous bladder irrigation (2.7% versus 0%, p = 0.027).
The findings of the linear regression conducted to explore the relationship between conceptually-driven surrogate measures of patients' clinical status (STS score and baseline left ventricular ejection fraction (LVEF)), procedural changes (mode of anaesthesia and avoidance of urinary catheter) and procedure time highlighted some potential insights that warrant further study. When time from the patient's entry to exit was regressed on these four candidate predictors, the only variable that was significant was peri-procedure urinary catheterization; the model as a whole only explained 3.6% of the variation to our understanding of procedure time (R 2 = .036, F(4,267) = 2.476, p = .045). Compared with the non-urinary catheter group, the urinary catheter group's entry to exit time was predicted to increase by approximately 9 min, controlling for STS, baseline LVEF and anaesthesia type. The use of a retrospective chart review enabled a low incidence of missing data. There was less than 5% missing information for the variables reported; thus, this was treated as statistically inconsequential to the exploratory aims of the evaluation.
Discussion
Limitations
Findings must be interpreted with caution given the study design and the multiple and potentially interrelated practice changes under way during the study period. Observational studies are inherently limited by the lack of random assignment that leads to non-equivalent test groups. 23 The generalizability of the results is further constrained by the limitations of the study design. Although the rapid pace of change in TAVI case selection, technology and procedural approach 1 limit the inferences that can be made from the study, the validity of the findings is strengthened by the relatively stable clinical environment of the Vancouver TAVI Program, a well-established group that has treated over 1700 patients with primarily contemporary technology and consistent outcomes. 3 Further, the conduct of a detailed and systematic chart review of a large cohort attests to the rigour employed to mitigate the inherent limitations of studying quality improvement in a rapidly evolving clinical context.
From historical to minimalist TAVI
The successful transition to a standard practice of avoiding a urinary catheter for TAVI was a pivotal component of the multifaceted shift from historical to minimalist TAVI. The change in practice was associated with a significant decrease in elimination-related complications. These findings were not unexpected given the consistent conclusions of previous research; our study mirrors existing literature that attributes the use of a urinary catheter to worse outcomes in the elderly, a patient population at heightened risk for post-operative complications due to their impaired physiological reserve. 24 Contemporary TAVI is evolving; multiple centres are adopting increasingly minimalist approaches matched to the technology and, more importantly, aimed at maintaining patients' fragile balance of reserve and stressors. 25 In addition to the now-established practice of avoiding a urinary catheter, the Vancouver program performs 45% of procedures in a cardiac catheterization laboratory while only 9% have a general anaesthesia. Similar changes in practice are occurring across regions. 26 In 2014, the European Society of Cardiology Transcatheter Valve Treatment Sentinel Registry reported a rapid increase in the adoption of local anaesthesia from 37.5% in 2011 to 57% a year later without negative effects on outcomes. 27 The significantly shorter procedure times seen in the later cohort must be interpreted with particular caution. The conceptually-driven regression analysis was limited by the number of predictor variables considered, and the findings may be attributed to the bundle of peri-procedure changes, of which the avoidance of urinary catheterization was one intervention. Although the model is not statistically convincing, there may be clinical significance in demonstrating reduced procedure times associated with the avoidance of urinary catheterization to increase program capacity when performing up to four to five procedures in a single day. Further study is required to validate this finding.
The importance of case selection and managing vulnerabilities of the older adult
The identification of patients suitable for TAVI continues to evolve. 28, 29 The study would have been strengthened by propensity score matching to better parse the effects of the intervention and control the multiple variables at play. We decided that the design would have been jeopardized by the intersecting effects of changes in case selection and practice. We can speculate that differences in STS scores, severe pulmonary disease and pre-existing atrial fibrillation between the two cohorts may reflect a shift in the heart team's treatment decision. The implementation phase coincided with increased awareness of the identification of patients' expectations of treatment, 30 the factors associated with futility of treatment, 31 and new recommendations about incorporating a palliative approach for patients unlikely to derive quantity and quality of life benefit from TAV. 32 There were no differences in in-hospital outcomes; this attests to the consistent outcomes achieved in a mature and high volume TAVI centre. The low event rate does not preclude a potential type II statistical error in the comparisons. Nevertheless, the detailed examination of elimination-related complications potentially signals the contributions of the avoidance of urinary catheterization to managing the unique health vulnerabilities of the older TAVI population.
Implications for practice: Transforming the way we care for TAVI patients
Change management of historical clinical practices is challenging, even in the setting of TAVI, a relatively new treatment option. Barriers were overcome thanks to the engagement of cardiovascular nursing and other champions, raised awareness, and the implementation of an evaluation framework. In view of the unique and extensive involvement of multiple members of the TAVI heart team throughout patients' admission, 9,33 the commitment of multidisciplinary stakeholders who share a common objective to keep pace with advances in TAVI was essential.
This study provides new evidence that the avoidance of urinary catheterization is associated with reduced rate of in-hospital complications. The findings support the inclusion of the practice in the bundle of care aimed at optimizing outcomes in the contemporary TAVI era, and is in keeping with international recommendations for the care of the older adult and other patients. Further research is needed to parse the effects of multifaceted interventions to transition to a minimalist approach and promote early discharge home. To this end, the Centre for Heart Valve Innovation at St. Paul's Hospital has incorporated the avoidance of a urinary catheter in a prospective study to demonstrate the feasibility, safety and reproducibility of the Vancouver Multimodality, Multidisciplinary but Minimalist TAVR (3M TAVR) clinical pathway. In collaboration with 13 North American sites, the study is currently under way [ClinicalTrials.gov identifier: NCT02287662]. It aims to use existing technology and procedural expertise, current evidence about objective anatomical and functional screening, and a standardized clinical pathway to demonstrate the safety and reproducibility of next day discharge home while sustaining optimal outcomes. The study will build on the lessons learned in this study, and provide robust evidence about the value of overcoming the challenges associated with the seemingly benign change in practice to avoid urinary catheterization in the care of TAVI patients. 
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